GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Perfect Medical Industry Co 6543.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

16.80

+0.60%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 779.0m

FY2016FY2025

Net income

TWD 54.2m

FY2016FY2025

Free cash flow

−TWD 91.3m

FY2016FY2025

Shareholders' equity

TWD 823.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 779.0mTWD 744.2mTWD 734.1mTWD 677.0mTWD 724.6mTWD 807.8mTWD 675.7mTWD 572.8mTWD 533.8mTWD 468.1m
Gross profitTWD 200.8mTWD 238.2mTWD 200.6mTWD 134.4mTWD 209.5mTWD 252.7mTWD 152.6mTWD 139.4mTWD 116.2mTWD 94.8m
Research and developmentTWD 15.8mTWD 9.3mTWD 7.4mTWD 7.1mTWD 5.6mTWD 7.6mTWD 5.1mTWD 4.7mTWD 9.2mTWD 9.1m
Operating incomeTWD 51.3mTWD 91.3mTWD 58.4mTWD 3.7mTWD 58.5mTWD 129.7mTWD 50.4mTWD 45.7mTWD 29.0mTWD 7.6m
Net incomeTWD 54.2mTWD 89.1mTWD 40.1mTWD 14.3mTWD 38.8mTWD 100.7mTWD 36.4mTWD 37.4mTWD 21.3mTWD 217,000
Diluted earnings per share0.981.590.870.320.942.340.881.040.610.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.34bnTWD 1.11bnTWD 988.5mTWD 957.1mTWD 1.04bnTWD 939.5mTWD 679.0mTWD 564.1mTWD 551.6mTWD 484.2m
Cash and short-term investments—TWD 239.4mTWD 180.4mTWD 92.7mTWD 119.2mTWD 143.0mTWD 7.8mTWD 35.3mTWD 54.6mTWD 59.1m
Total liabilitiesTWD 520.9mTWD 310.9mTWD 324.7mTWD 307.5mTWD 458.4mTWD 359.7mTWD 10.5mTWD 125.7mTWD 131.6mTWD 98.6m
DebtTWD 132.6mTWD 184.8mTWD 212.0mTWD 208.3mTWD 320.0mTWD 204.2mTWD 62.0mTWD 35.7mTWD 29.5mTWD 3.3m
Shareholders' equityTWD 823.1mTWD 803.9mTWD 663.8mTWD 649.6mTWD 578.0mTWD 579.8mTWD 517.1mTWD 438.5mTWD 419.9mTWD 385.6m
Shares outstanding55m56m46m44m41m43m41m36m35m29m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 107.6mTWD 143.5mTWD 149.9mTWD 105.6mTWD 4.4mTWD 118.2mTWD 96.0mTWD 31.7mTWD 62.2mTWD 22.9m
Capital spending−TWD 198.9m−TWD 99.2m−TWD 66.3m−TWD 52.7m−TWD 103.6m−TWD 144.5m−TWD 49.2m−TWD 37.6m−TWD 111.8m−TWD 30.7m
Free cash flow−TWD 91.3mTWD 44.3mTWD 83.6mTWD 52.9m−TWD 99.1m−TWD 26.3mTWD 46.8m−TWD 6.0m−TWD 49.7m−TWD 7.8m
Dividends paid−TWD 45.8m−TWD 65.1m−TWD 16.9m−TWD 14.4m−TWD 58.8m−TWD 27.4m−TWD 27.4m−TWD 20.6m−TWD 17.2m—

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 355.9mTWD 381.4mTWD 362.8mTWD 397.8mTWD 336.3mTWD 347.4mTWD 329.6mTWD 362.3m
Gross profitTWD 101.6mTWD 113.9mTWD 118.0mTWD 121.4mTWD 79.2mTWD 59.0mTWD 75.4mTWD 104.8m
Operating incomeTWD 32.2mTWD 46.2mTWD 45.1mTWD 43.8mTWD 14.5m−TWD 2.5mTWD 25.0mTWD 32.9m
Net incomeTWD 27.9mTWD 44.6mTWD 44.5mTWD 25.7mTWD 14.4mTWD 6.0mTWD 8.2mTWD 19.4m
Diluted earnings per share0.510.800.790.560.310.140.190.47
Cash from operationsTWD 35.0mTWD 91.0mTWD 55.0mTWD 76.0mTWD 76.0mTWD 53.0m—TWD 2.0m
Capital spending−TWD 39.0m−TWD 61.0m−TWD 35.0m−TWD 27.0m−TWD 36.0m−TWD 20.0m—−TWD 51.0m
Free cash flow−TWD 4.0mTWD 30.0mTWD 20.0mTWD 49.0mTWD 40.0mTWD 33.0m—−TWD 49.0m
Total assetsTWD 1.23bnTWD 1.11bnTWD 1.12bnTWD 988.5mTWD 969.6mTWD 957.1m—TWD 1.04bn
Cash and short-term investmentsTWD 343.4mTWD 239.4mTWD 289.3mTWD 180.4mTWD 131.9mTWD 92.7m—TWD 119.2m
DebtTWD 352.5mTWD 184.4mTWD 190.4mTWD 166.7mTWD 115.4mTWD 98.4m—TWD 258.0m
Shareholders' equityTWD 757.6mTWD 803.9mTWD 791.1mTWD 663.8mTWD 654.7mTWD 649.6m—TWD 578.0m

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin25.8%32.0%27.3%19.9%28.9%31.3%
Operating margin10.1%14.9%8.0%3.3%9.1%16.9%
Net margin7.0%12.0%5.5%2.1%5.4%12.5%
Return on equity6.6%11.1%6.0%2.2%6.7%17.4%
Return on assets4.0%8.0%4.1%1.5%3.7%10.7%
Free cash flow yield32.3%25.2%27.2%20.7%15.2%35.5%
Revenue growth4.7%1.4%8.4%-6.6%-10.3%19.5%
Earnings growth-39.1%122.3%180.9%-63.2%-61.5%176.3%
Current ratio1.71x3.01x1.71x2.11x1.32x1.87x
Debt to equity0.16x0.23x0.32x0.32x0.54x0.18x
Equity ratio61.2%72.1%67.1%67.9%55.8%61.7%
Interest coverage11.47x29.87x13.42x5.04x22.19x66.37x
R&D as a share of sales2.0%1.3%1.0%1.1%0.8%0.9%
Buybacks as a share of market value1.6%-21.5%-4.0%-7.3%3.9%-4.4%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue4.8%-0.7%—
Operating income141.3%-16.9%—
Net income56.1%-11.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin28.8%26.4%27.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings28.217.420.749.419.611.219.3
Price to sales2.02.11.11.01.11.41.0

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 6 May 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.1920.8341.1850.3480.307
  • 1032886.2-for-1000000 split · 24 Aug 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.